Results 21 to 30 of about 1,020 (190)

Why Deprescribing Instead of Not Prescribing? [PDF]

Geriatrics, Gerontology and Aging
Prescribing medications involves complex cognitive processes, and mistakes in prescription can cause serious adverse events. Deprescribing is one of the last opportunities to prevent patient harm from the use of drugs that should be avoided, especially ...
Welma Wildes Amorim, Luiz Carlos Passos, Marcio Galvão Oliveira   +2 more
doaj   +3 more sources

Improving the feasibility of deprescribing proton pump inhibitors: GPs’ insights on barriers, facilitators, and strategies

Frontiers in Pharmacology
IntroductionThe prevalent overprescribing of proton pump inhibitors (PPIs) poses health risks from prolonged use. GPs play a key role in initiating deprescribing PPIs, so understanding their decision-making factors and strategies to improve feasibility ...
Nuša Japelj, Lea Knez, Lea Knez, Davorina Petek, Nejc Horvat   +4 more
exaly   +3 more sources

‘Do I actually even need all these tablets?’ A qualitative study exploring deprescribing decision-making for people in receipt of palliative care and their family members [PDF]

Palliative Medicine
Anna Robinson, Jesse Jansen, Adam Todd
exaly   +5 more sources

Finding the Sweet Spot: An Interactive Workshop on Diabetes Management in Older Adults

MedEdPORTAL: the Journal of Teaching and Learning Resources, 2019
Introduction Intensive glucose lowering in older adults with diabetes leads to increased risks with minimal benefits. Surveys indicate that clinician confidence for individualizing glycemic goals and regimens remains low.
Laura K Triantafylidis, Chelsea E Hawley
exaly   +3 more sources

Effectiveness of a multidisciplinary team-delivered deprescribing intervention for patients with chronic kidney disease: a protocol for a randomised controlled trial [PDF]

Journal of Pharmaceutical Policy and Practice
Introduction Inappropriate polypharmacy is prevalent among patients with chronic kidney disease (CKD), and can be mitigated by deprescribing. We aim to evaluate the clinical and economic impact of a multidisciplinary deprescribing programme in Qatar’s ...
Amani Zidan, Abdullah Hamad, Rania Ibrahim, Mohamed El-Kadi, Hasan El-Malki, Mohamed Al-Esnawi, Safeya Habib, Muhammad Abdul Hadi, Fatema Babiker, Daoud Al-Badriyeh, Ahmed Awaisu   +10 more
doaj   +2 more sources

Deprescription in Palliative Care

Cureus, 2023
Individuals with limited life expectancy represent a significant proportion of healthcare consumers and are usually patients with multiple diseases and high levels of frailty. Polypharmacy and the prescription of long lists of drugs are frequent in patients with reduced life expectancy and often, as the patient's health status deteriorates, the list of
Cabrera, Joana A, Mota, Margarida, Pais, Carmen, Morais, Anabela   +3 more
openaire   +2 more sources

Towards optimal use of antithrombotic therapy of people with cancer at the end of life: a research protocol for the development and implementation of the SERENITY shared decision support tool Thrombosis Research [PDF]

, 2023
Background: Even though antithrombotic therapy has probably little or even negative effects on the well-being of people with cancer during their last year of life, deprescribing antithrombotic therapy at the end of life is rare in practice.
Abbel, D., Accassat, S., Achterberg, W.P., Akbari, A., Arfuch, V.M., Baddeley, E., Bax, J.J., Becker, D., Bergmeijer, B., Bertoletti, L., Blom, J.W., Calvetti, A., Cannegieter, S.C., Castro, L., Chavannes, N.H., Coma-Auli, N.R., Couffignal, C.P, Edwards, A., Edwards, M., Enggaard, H., Font, C., Gava, A., Geersing, G.J., Geijteman, E.C.T., Goedegebuur, J., Greenley, S., Gregory, C., Gussekloo, J., Hoffmann, I., Hout, van den W.B. P., Huisman, M.V., Højen, A.A., Jacobsen, S., Jagosh, J., Johnson, Miriam, Juffermans, C.C.M., Jørgensen, L., Kempers, E.K., Klok, F.A., Konstantinides, S., Kroder, A.F., Kruip, M.J.H.A., Lafaie, L., Langendoen, J.W., Larsen, T.B., Lifford, K., Linden, van der Y.M., Mahé, Maiorana, L., Maraveyas, A., Martens, E.S.L., Mayeur, D., Mens van, T.E., Mohr, K., Mooijaart, S.P., Murtagh, F.E.M., Nelson, A., Nielsen, P.B., Noble, S.I.R., Ording, A.G., Pearson, M., Poenou, G., Portielje, J.E.A., Raczkiewicz, D., Rasmussen, K., Schippers, I., Seddon, K., Sexton, K., Sivell, S, Skjøth, F., Szmit, S., Søgaard, M., Trinks-Roerdink, E., Trompet, S., Vassal, P., Visser, C.M., Vliet, van L.M., Wilson, E., Ørskov, M.   +78 more
core   +13 more sources

Implementation frameworks for polypharmacy management within healthcare organisations: a scoping review. [PDF]

, 2023
Several guidelines support polypharmacy management in individual patients. More organisational-level focus is needed on the use of implementation frameworks.
Al Bulushi, S., Cunningham, S., Grant, A., McIntosh, T., Stewart, D.   +4 more
core   +2 more sources

Identification of barriers, enablers and interventions to inform deimplementation of low-value care in emergency medicine practice: A protocol for a mixed methods scoping review informed by the Theoretical Domains Framework [PDF]

, 2022
INTRODUCTION: Low-value care can lead to patient harm, misdirected clinician time and wastage of finite healthcare resources. Despite worldwide endeavours, deimplementing low-value care has proved challenging.
Cardona, Magnolia, Carlisle, Karen, Drever, Natalie, Evans, Rebecca, Gangathimmaiah, Vinay, Moodley, Nishila, Sen Gupta, Tarun   +6 more
core   +2 more sources

The pharmacological deprescription in elderly patients

Italian Journal of Medicine, 2023
N ...
Ali, Chelsey, Huang, Daniel, Tugwete, Charlene, Canale, Stefano Del, Maio, Vittorio   +4 more
openaire   +2 more sources